In earlier releases of the KDIGO guidelines, clinicians were advised to maintain phosphate in the normal range in patients with CKD. However, while acknowledging that preventing, rather than treating, hyperphosphatemia may be beneficial in patients with advanced CKD, the working group believes more data are needed to ascertain the risk/benefit ratio. Thus, current recommendations suggest phosphate-lowering therapies be administered to patients with progressive or persistent hyperphosphatemia only.
Learn details about the treatment of hyperphosphatemia in patients with CKD.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: A. Brent Alper. Fast Five Quiz: Chronic Kidney Disease (CKD) Hyperphosphatemia - Medscape - Apr 26, 2021.